Characteristics at Time of Study Entry for 249 Patients Entered on CALGB 9022
| Age (yrs) | |
| Median, 41 (range, 16-59) | |
| Years | No. of Patients |
| <30 | 57 (23%) |
| 30-39 | 63 (25%) |
| 40-49 | 63 (25%) |
| 50-59 | 66 (27%) |
| Sex | |
| Males: | 113 (45%) |
| Females: | 136 (55%) |
| Race | |
| White: | 201 (81%) |
| Black: | 22 (9%) |
| Other: | 26 (10%) |
| Performance status | |
| 0 | 80 (32%) |
| 1 | 113 (45%) |
| 2 | 41 (16%) |
| 3 | 10 (4%) |
| 4 | 5 (2%) |
| FAB classification* | |
| M0 | 5 (2%) |
| M1 | 40 (16%) |
| M2 | 74 (30%) |
| M3 | 34 (14%) |
| M4 | 57 (23%) |
| M5 | 10 (4%) |
| M6 | 1 (<1%) |
| Mixed | 3 (1%) |
| AML, other | 24 (10%) |
| Hematologic values | |
| Hemoglobin (gm/dL; n = 245) | Median, 9.2 (range, 3.5-22.6) |
| Platelets (×109/L; n = 248) | Median, 58.0 (range, 10-514) |
| WBC (×109/L; n = 248) | Median, 11.1 (range, 0.2-318.4) |
| Age (yrs) | |
| Median, 41 (range, 16-59) | |
| Years | No. of Patients |
| <30 | 57 (23%) |
| 30-39 | 63 (25%) |
| 40-49 | 63 (25%) |
| 50-59 | 66 (27%) |
| Sex | |
| Males: | 113 (45%) |
| Females: | 136 (55%) |
| Race | |
| White: | 201 (81%) |
| Black: | 22 (9%) |
| Other: | 26 (10%) |
| Performance status | |
| 0 | 80 (32%) |
| 1 | 113 (45%) |
| 2 | 41 (16%) |
| 3 | 10 (4%) |
| 4 | 5 (2%) |
| FAB classification* | |
| M0 | 5 (2%) |
| M1 | 40 (16%) |
| M2 | 74 (30%) |
| M3 | 34 (14%) |
| M4 | 57 (23%) |
| M5 | 10 (4%) |
| M6 | 1 (<1%) |
| Mixed | 3 (1%) |
| AML, other | 24 (10%) |
| Hematologic values | |
| Hemoglobin (gm/dL; n = 245) | Median, 9.2 (range, 3.5-22.6) |
| Platelets (×109/L; n = 248) | Median, 58.0 (range, 10-514) |
| WBC (×109/L; n = 248) | Median, 11.1 (range, 0.2-318.4) |
82% were reviewed and classified in a CALGB central morphology laboratory; the remainder represent institutional assessments.